Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences

University of the Witwatersrand, Johannesburg, Gauteng, South Africa
American journal of obstetrics and gynecology (Impact Factor: 3.97). 10/2007; 197(3 Suppl):S64-71. DOI: 10.1016/j.ajog.2007.03.002
Source: PubMed

ABSTRACT Diagnosing human immunodeficiency virus (HIV) infection in infants is difficult because maternal HIV antibodies cross the placenta, causing positive serologic tests in HIV-exposed infants for the first several months of life. Early definitive diagnosis of HIV requires virologic testing such as polymerase chain reaction (PCR), which is the diagnostic standard in resource-rich settings but has been too complex and expensive for widespread use in most countries with high HIV prevalence. Early PCR testing can help HIV-infected infants access treatment, provide psychosocial benefits for families of uninfected infants, and help programs for prevention of mother-to-child transmission of HIV monitor their effectiveness. HIV testing, including PCR, is increasingly available for infants in resource-limited settings, but there are many barriers and complex policy decisions that need to be addressed before universal early testing can become standard. This paper reviews challenges and progress in the field and suggests ways to facilitate early infant testing in resource-limited settings.

Download full-text


Available from: Gayle Sherman, Jun 24, 2015
  • Source
    Genetic Diversity in Microorganisms, 02/2012; , ISBN: 978-953-51-0064-5
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: CONCLUSIONS We have developed a low cost, rapid ultra-sensitive p24 antigen dipstick assay for infant HIV screening in resource-limited settings. The assay utilizes ultra-sensitive carbon nanoparticles functionalized with antibodies against HIV p24 antigen as the reporter label. To disrupt the immune complexes due to maternal antibodies, a rapid heat shock pretreatment method was developed and utilized prior to performing the dipstick assay. In testing archived infant samples obtained from WITS, the assay showed good performance (93% sensitivity and 98% specificity between ages 2 and 6 months). In this study, the performance of the assay was evaluated with 708 blinded infant samples at the National Health Laboratory Service Virology Laboratory, Groote Schuur Hospital, Cape Town, South Africa. The p24 antigen rapid test achieved 90.6% sensitivity and 99.8% specificity among infants younger than 6 months. Overall among all infants younger than one year, the assay sensitivity and specificity were 85.9% and 99.8% respectively. We have thus demonstrated that the p24 antigen rapid test exhibits good accuracy among samples from the target population in Sub-Saharan Africa. By increasing access and reducing the costs involved in HIV-1 testing, infected infants can be identified in a timely manner using the p24 antigen dipstick assay. Prompt diagnosis is critical in the path to initiating treatment, thereby greatly enhancing the quality of life and reducing the mortality rate among these children.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Early infant diagnosis (EID) of HIV-1 infection confers substantial benefits to HIV-infected and HIV-uninfected infants, to their families, and to programs providing prevention of mother-to-child transmission (PMTCT) services, but has been challenging to implement in resource-limited settings. In order to correctly inform parents/caregivers of infant infection status and link HIV-infected infants to care and treatment, a 'cascade' of events must successfully occur. A frequently cited barrier to expansion of EID programs is the cost of the required laboratory assays. However, substantial implementation barriers, as well as personnel and infrastructure requirements, exist at each step in the cascade. In this update, we review challenges to uptake at each step in the EID cascade, highlighting that even with the highest reported levels of uptake, nearly half of HIV-infected infants may not complete the cascade successfully. We next synthesize the available literature about the costs and cost effectiveness of EID programs; identify areas for future research; and place these findings within the context of the benefits and challenges to EID implementation in resource-limited settings.
    BMC Medicine 05/2011; 9(1):59. DOI:10.1186/1741-7015-9-59 · 7.28 Impact Factor